A new study has found that one in five teens and young adults who are going through treatment for drug or alcohol abuse may have traits characteristic of a previously unrecognized autism spectrum disorder (ASD).
The study has been published in ‘The American Journal on Addictions’. They found that among patients with an average age of 18.7 years being treated in an outpatient substance use disorder (SUD) clinic, 20 per cent had elevated scores on the Social Responsiveness Scale-2 (SRS-2), a parent- or teacher-reported measure that has been shown to reliably identify the presence and severity of social impairment among individuals along the autism spectrum and to distinguish autism from other disorders.
The study is the first to look at the prevalence of previously undiagnosed autistic traits among teens and young adults with SUD, said lead author James McKowen, PhD, of the Addiction Recovery Management Service at MGH and Harvard Medical School. “Usually studies of substance use disorder in autism are done in those with an autism diagnosis already,” he said.
“We have looked at this question from the other side, asking how many people with substance use disorder have autism,” he added. The researchers asked parents of 69 youths reporting for the first time to a speciality outpatient psychiatric SUD clinic to fill out the SRS-2 form.
The form is designed to measure an individual’s social awareness, social cognition (thinking about other people and interactions with them), social communication, social motivation, restricted interests and repetitive behaviours.
They found that although there were few differences between those with elevated autistic trait scores and those with lower, non-autistic scores in terms of demographic or psychiatric factors, the adolescents with higher SRS-2 scores had a nearly eightfold higher likelihood of stimulant use disorder and a fivefold higher risk for opioid use disorder.
The findings highlighted the importance of assessing patients in a SUD treatment setting for autistic traits, the researchers wrote.
“For clinicians, the big takeaway point from this study is that we need to get better at screening and certainly training in the presence of autism spectrum disorder, because many clinicians treat substance use disorder but don’t have speciality developmental training, particularly for issues around autism,” McKowen said.
“For parents, the big takeaway is that if you suspect that your child may have an autism spectrum issue or if school personnel have suggested that your child may have autistic traits, you should certainly get that assessed, and let your clinicians know whether your child has had a prior diagnosis of ASD,” he added.
The researchers are developing a free clinical therapy protocol that can help clinicians better address the issues of autistic traits in patients with SUD. Study co-authors included Diana Woodward, BA, Maura DiSalvo, MPH, Vinod Rao, MD, PhD, Julia Greenbaum, BA, Gagan Joshi, MD, and Timothy E. Wilens, MD, from MGH, and Amy M. Yule, MD, from Boston University School of Medicine and Boston Medical Center. The study was supported by grants from the Demarest Lloyd, Jr. Foundation.
